HTB news: reduced dosing, stock-outs in Zimbabwe, RIO Q&A and more

5 May 2025. Related: News.

Reduced dosing: a possible crisis response to ART stock-outs and closed clinics (5 MAY 2025)
Results from using less-than-daily dosing in seven RCTs.
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news (4 MAY 2025)
Links to updated reports about limited access to ART in Zimbabwe, plus plans for PEPFAR and UNAIDS.
The RIO study: Q&A about controlling HIV with bNAbs (21 APRIL 2025)
Non-technical Q&A on first results presented at CROI and BHIVA conferences.
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years (20 APRIL 2025)
Access to lenacapavir in the UK is now on-hold because of the failure or NHS England and Gilled to agree a price more than 30 months after approval in the UK.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs (13 APRIL 2025)
A focus on options after viral failure on CAB/RPV/LA at CROI 2025 and a recent journal scan.

Please subscribe to receive a free email every 3-4 weeks of the latest news.

Reports will also be posted to social media at the same time.